Persistent pulmonary hypertension of the newborn in late preterm and term infants in California

Pediatrics

Volumn 139, Issue 1, 2017, Pages

  Steurer, Martina A ^a   Jelliffe Pawlowski, Laura L ^a,b   Baer, Rebecca J ^b,c   Partridge, J Colin ^a   Rogers, Elizabeth E ^a   Keller, Roberta L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLACK PERSON; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; FEMALE; GESTATIONAL AGE; HISPANIC; HUMAN; ICD-9; INCIDENCE; INFANT MORTALITY; LARGE FOR GESTATIONAL AGE; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL DIABETES MELLITUS; MATERNAL OBESITY; MULTIPLE PREGNANCY; NEWBORN; NEWBORN INFECTION; PERSISTENT PULMONARY HYPERTENSION; POSITIVE END EXPIRATORY PRESSURE; PREGNANCY DIABETES MELLITUS; PREMATURITY; PRIORITY JOURNAL; RACE DIFFERENCE; RESPIRATORY TRACT MALFORMATION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMALL FOR DATE INFANT; UNITED STATES; CALIFORNIA; CROSS-SECTIONAL STUDY; FACTUAL DATABASE; MEDICAL RECORD; MORTALITY; PERSISTENT FETAL CIRCULATION SYNDROME; SURVIVAL RATE;

CALIFORNIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; FEMALE; GESTATIONAL AGE; HOSPITAL RECORDS; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; PERSISTENT FETAL CIRCULATION SYNDROME; RISK FACTORS; SURVIVAL RATE;

EID: 85009101185     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-1165     Document Type: Article

References (50)

1. Oishi PE, Keller RL. When persistent pulmonary hypertension of the newborn persists. Pediatr Crit Care Med. 2012;13(2):224-225
2. Steinhorn RH. Neonatal pulmonary hypertension. Pediatr Crit Care Med. 2010;11(suppl 2):S79-S84
3. Thureen PJ, Hall DM, Hoffenberg A, Tyson RW. Fatal meconium aspiration in spite of appropriate perinatal airway management: pulmonary and placental evidence of prenatal disease. Am J Obstet Gynecol. 1997;176(5):967-975
4. Walsh-Sukys MC, Tyson JE, Wright LL, et al. Persistent pulmonary hypertension of the newborn in the era before nitric oxide: practice variation and outcomes. Pediatrics. 2000;105(1 pt 1):14-20
5. Hageman JR, Adams MA, Gardner TH. Persistent pulmonary hypertension of the newborn. Trends in incidence, diagnosis, and management. Am J Dis Child. 1984;138(6):592-595
6. Roberts JD Jr, Fineman JR, Morin FC III, et al; The Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N Engl J Med. 1997;336(9):605-610
7. Clark RH, Kueser TJ, Walker MW, et al; Clinical Inhaled Nitric Oxide Research Group. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N Engl J Med. 2000;342(7):469-474
8. Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in fullterm and nearly full-term infants with hypoxic respiratory failure. N Engl J Med. 1997;336(9):597-604
9. Reece EA, Moya F, Yazigi R, Holford T, Duncan C, Ehrenkranz RA. Persistent pulmonary hypertension: assessment of perinatal risk factors. Obstet Gynecol. 1987;70(5):696-700
10. Hernández-Díaz S, Van Marter LJ, Werler MM, Louik C, Mitchell AA. Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics. 2007;120(2). Available at: www.pediatrics.org/cgi/content/full/120/2/e272
11. Van Marter LJ, Leviton A, Allred EN, et al. Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy. Pediatrics. 1996;97(5):658-663
12. Bearer C, Emerson RK, O'Riordan MA, Roitman E, Shackleton C. Maternal tobacco smoke exposure and persistent pulmonary hypertension of the newborn. Environ Health Perspect. 1997;105(2):202-206
13. Baer RJ, Chambers CD, Jones KL, et al. Maternal factors associated with the occurrence of gastroschisis. Am J Med Genet A. 2015;167(7):1534-1541
14. Baer RJ, Lyell DJ, Norton ME, Currier RJ, Jelliffe-Pawlowski LL. First trimester pregnancy-associated plasma protein-A and birth weight. Eur J Obstet Gynecol Reprod Biol. 2016;198:1-6
15. Jelliffe-Pawlowski LL, Norton ME, Baer RJ, Santos N, Rutherford GW. Gestational dating by metabolic profile at birth: A California cohort study. Am J Obstet Gynecol. 2016;214(4):511. e1-511.e13
16. Stey A, Barnert ES, Tseng CH, et al. Outcomes and costs of surgical treatments of necrotizing enterocolitis. Pediatrics. 2015;135(5). Available at: www.pediatrics.org/cgi/content/full/135/5/e1190
17. Gage S, Kan P, Lee HC, et al. Maternal Asthma, Preterm Birth, and Risk of Bronchopulmonary Dysplasia. J Pediatr. 2015;167(4):875-880.e1
18. Jelliffe-Pawlowski LL, Norton ME, Shaw GM, et al Risk of critical congenital heart defects by nuchal translucency norms. Am J Obstet Gynecol. 2015;212(4):518.e1-e10
19. Crisham Janik MD, Newman TB, Cheng YW, Xing G, Gilbert WM, Wu YW. Maternal diagnosis of obesity and risk of cerebral palsy in the child. J Pediatr. 2013;163(5):1307-1312
20. Huybrechts KF, Bateman BT, Palmsten K, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015;313(21):2142-2151
21. Palmsten K, Huybrechts KF, Kowal MK, Mogun H, Hernández-Díaz S. Validity of maternal and infant outcomes within nationwide Medicaid data. Pharmacoepidemiol Drug Saf. 2014;23(6):646-655
22. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996;87(2):163-168
23. Kotelchuck M. An evaluation of the Kessner Adequacy of Prenatal Care Index and a proposed Adequacy of Prenatal Care Utilization Index. Am J Public Health. 1994;84(9):1414-1420
24. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75-84
25. Peelen MJCS, Kazemier BM, Ravelli ACJ, et al. Impact of fetal gender on the risk of preterm birth, a national cohort study. Acta Obstet Gynecol Scand. 2016;95(9):1034-1041
26. Shih T, Peneva D, Xu X, et al. The rising burden of preeclampsia in the United States impacts both maternal and child health. Am J Perinatol. 2016;33(4):329-338
27. Long PA, Abell DA, Beischer NA. Parity and pre-eclampsia. Aust N Z J Obstet Gynaecol. 1979;19(4):203-206
28. Srinivas SK, Edlow AG, Neff PM, Sammel MD, Andrela CM, Elovitz MA. Rethinking IUGR in preeclampsia: dependent or independent of maternal hypertension? J Perinatol. 2009;29(10):680-684
29. Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69(1):1-7
30. Magann EF, Haas DM, Hill JB, Chauhan SP, Watson EM, Learman LA. Oligohydramnios, small for gestational age and pregnancy outcomes: an analysis using precise measures. Gynecol Obstet Invest. 2011;72(4):239-244
31. Cleary-Goldman J, Malone FD, Vidaver J, et al; FASTER Consortium. Impact of maternal age on obstetric outcome. Obstet Gynecol. 2005;105(5 pt 1):983-990
32. Metzger BE, Lowe LP, Dyer AR, et al; HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991-2002
33. Mitanchez D, Burguet A, Simeoni U. Infants born to mothers with gestational diabetes mellitus: mild neonatal effects, a long-term threat to global health. J Pediatr. 2014;164(3):445-450
34. Radaelli T, Varastehpour A, Catalano P, Hauguel-de Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes. 2003;52(12):2951-2958
35. Ferdinand KC, Nasser SA. Racial/ethnic disparities in prevalence and care of patients with type 2 diabetes mellitus. Curr Med Res Opin. 2015;31(5):913-923
36. Blumenshine P, Egerter S, Barclay CJ, Cubbin C, Braveman PA. Socioeconomic disparities in adverse birth outcomes: A systematic review. Am J Prev Med. 2010;39(3):263-272
37. Tseng W, Sutter ME, Albertson TE. Stimulants and the lung: review of literature. Clin Rev Allergy Immunol. 2014;46(1):82-100
38. Sackett DL. Bias in analytic research. J Chronic Dis. 1979;32(1-2): 51-63
39. Delgado-Rodríguez M, Llorca J. Bias. J Epidemiol Community Health. 2004;58(8):635-641
40. Walther FJ, Benders MJ, Leighton JO. Persistent pulmonary hypertension in premature neonates with severe respiratory distress syndrome. Pediatrics. 1992;90(6):899-904
41. Torday JS, Nielsen HC, Fencl MM, Avery ME. Sex differences in fetal lung maturation. Am Rev Respir Dis. 1981;123(2):205-208
42. Perelman RH, Palta M, Kirby R, Farrell PM. Discordance between male and female deaths due to the respiratory distress syndrome. Pediatrics. 1986;78(2):238-244
43. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840-846
44. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: The link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25(1):4-7
45. Radaelli T, Lepercq J, Varastehpour A, Basu S, Catalano PM, Hauguel-De Mouzon S. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol. 2009;201(2):209.e1-209.e10
46. Rozance PJ, Seedorf GJ, Brown A, et al. Intrauterine growth restriction decreases pulmonary alveolar and vessel growth and causes pulmonary artery endothelial cell dysfunction in vitro in fetal sheep. Am J Physiol Lung Cell Mol Physiol. 2011;301(6):L860-L871
47. Moorman JE, Akinbami LJ, Bailey CM, et al. National surveillance of asthma: United States, 2001-2010. Vital Health Stat 3 2012; (35):1-58
48. Cummings P. Missing data and multiple imputation. JAMA Pediatr. 2013;167(7):656-661
49. Barros AJ, Hirakata VN. Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio. BMC Med Res Methodol. 2003;3:21
50. Sarrazin MSV, Rosenthal GE. Finding pure and simple truths with administrative data. JAMA. 2012;307(13):1433-1435